Adam Havey Emergent Bio Solutions Inc. (EBS) insider trading activity

Adam Havey is EVP, Business Operations of Emergent BioSolutions Inc.. Currently has a direct ownership of 174,398 shares of EBS, which is worth approximately $1.45 Million. The most recent transaction as insider was on Jun 09, 2023, when has been sold 73,847 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 174K

0% 3M change

0% 12M change

Total Value Held $1.45 Million

Adam Havey Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 09 2023	BUY Grant, award, or other acquisition	-	73,847 Added 29.75%	174,398 Common Stock
Mar 02 2023	BUY Grant, award, or other acquisition	-	18,462 Added 15.51%	100,551 Common Stock
Feb 28 2023	SELL Payment of exercise price or tax liability	$12,355 $12.38 p/Share	998 Reduced 2.86%	33,927 Common Stock
Feb 24 2023	SELL Payment of exercise price or tax liability	$11,132 $13.71 p/Share	812 Reduced 2.35%	33,681 Common Stock
Feb 23 2023	SELL Payment of exercise price or tax liability	$6,177 $14.3 p/Share	432 Reduced 1.24%	34,493 Common Stock
Feb 08 2023	SELL Payment of exercise price or tax liability	$26,023 $13.25 p/Share	1,964 Reduced 5.32%	34,925 Common Stock
Feb 08 2023	BUY Grant, award, or other acquisition	-	95 Added 0.26%	36,889 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	50,145 Added 36.58%	86,939 Common Stock
Feb 28 2022	SELL Payment of exercise price or tax liability	$29,294 $39.64 p/Share	739 Reduced 0.85%	86,200 Common Stock
Feb 24 2022	SELL Payment of exercise price or tax liability	$35,165 $42.47 p/Share	828 Reduced 2.2%	36,794 Common Stock
Feb 23 2022	SELL Payment of exercise price or tax liability	$17,906 $42.23 p/Share	424 Reduced 1.11%	37,622 Common Stock
Feb 22 2022	SELL Payment of exercise price or tax liability	$83,615 $42.23 p/Share	1,980 Reduced 4.95%	38,046 Common Stock
Feb 22 2022	BUY Grant, award, or other acquisition	-	1,836 Added 4.39%	40,026 Common Stock
Mar 01 2021	SELL Open market or private sale	$3,702,550 $99.32 p/Share	37,279 Reduced 49.4%	38,190 Common Stock
Mar 01 2021	BUY Exercise of conversion of derivative security	$1,496,006 $40.13 p/Share	37,279 Added 38.99%	58,335 Common Stock
Feb 26 2021	SELL Payment of exercise price or tax liability	$142,908 $97.15 p/Share	1,471 Reduced 3.71%	38,190 Common Stock
Feb 24 2021	SELL Payment of exercise price or tax liability	$79,186 $93.49 p/Share	847 Reduced 2.09%	39,661 Common Stock
Feb 24 2021	BUY Grant, award, or other acquisition	-	7,488 Added 15.6%	40,508 Common Stock
Feb 09 2021	SELL Payment of exercise price or tax liability	$269,491 $123.45 p/Share	2,183 Reduced 6.2%	33,020 Common Stock
Feb 09 2021	BUY Grant, award, or other acquisition	-	2,518 Added 6.68%	35,203 Common Stock

Adam Havey

EVP, Business Operations

Gaithersburg, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EBS shares.

Notify only if

Value

Insider Trading

Get notified when an Emergent Bio Solutions Inc. insider buys or sells EBS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Emergent BioSolutions Inc.

Track Activities on EBS

Account